The primary focus of the hearing centered on Docket 0175, sponsored by Councilors Fitzgerald and Edward M. Flynn, which called for a discussion on kratom regulation. Concerns were raised about kratom’s accessibility and its potential to be mixed with other harmful substances, leading to dangerous outcomes. A doctor testified about the increasing availability of such substances to youth and emphasized the unregulated nature of kratom products, leading to a higher likelihood of individuals testing positive for fentanyl.

The hearing featured notable testimonies from individuals who have lost loved ones due to kratom use. Holly Trouville shared the tragic story of her son, Tyrell, whose death was attributed to kratom. She urged the council to impose a complete ban, criticizing the lobbying efforts of kratom advocates and pointing out that kratom is banned in all armed forces due to its risks. Similarly, Amy Lachman recounted the devastating impact of losing her nephew to kratom, describing claims of the substance’s safety as misleading and detrimental.

In addition to personal testimonies, Peter Babineaux, CEO of the GAP Foundation, pointed out the prevalence of kratom in Boston, available without age restrictions, quality control, or labeling requirements. He described kratom as challenging to detect in urine screenings, complicating treatment for individuals in recovery. Babineaux called for increased awareness and regulation, labeling kratom a harmful and highly addictive substance.

Deputy Commissioner PJ McCann of the Boston Public Health Commission provided an overview of kratom, describing it as a tropical tree native to Southeast Asia, often used to self-treat conditions like pain, anxiety, and opioid withdrawal. However, McCann emphasized the associated risks, including withdrawal symptoms and potential substance use disorder. He differentiated kratom from synthetic derivatives like seven-hydroxymitragynine (7-OH), which carry additional health risks due to their higher concentration of psychoactive substances.

Dr. Noni Estar, drawing from her medical experience in Lowell, highlighted the cultural history of kratom use among Southeast Asian populations and raised alarms about the rising concentrations of 7-OH in kratom products, posing significant health threats such as liver toxicity and respiratory issues. She called for increased regulatory action, noting that many states have already banned kratom.

The council also heard from Susan Cave, who shared the story of her son William’s death after consuming Raleigh Kratom. She emphasized the need for more regulation, stating that if bans had been in place earlier, her son might still be alive. Dan Gibbs recounted a similar tragedy involving his son Austin, whose death was confirmed to be due to kratom alone. Gibbs urged the council to consider these personal stories in their deliberations on kratom’s legality in Boston.

The discussion extended to the broader implications of substance regulation, with Stephen Fox urging the council to examine the licensing and zoning regulations governing smoke shops, which distribute various products, including kratom. The need for a city ordinance to prohibit kratom sales was reiterated, with an emphasis on public awareness and retailer compliance once notified of such substances’ unacceptability for sale.

The council members considered the potential for public service announcements to raise awareness about kratom’s risks, particularly targeting younger populations. There was also mention of legislative advocacy at the state level, with a focus on unified approaches to regulate kratom and similar substances.